Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (5113)	8/24/1998 5:25:00 AM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

August 24, 1998 (Reuters) - Anti-impotence drug Viagra will be available in the UAE (United Arab Emirates) from September 1, priced at 180 dirhams for a pack of four. A Pfizer <PFE.N> spokesman said the drug would only be available on prescription through pharmacies. ($1=3.67 dirhams) From Khaleej Times moneynet.com@NEWS-P1&Index=3&HeadlineURL=../News/NewsHeadlines.asp&DISABLE_FORM=

To: Anthony Wong who wrote (5113)	8/24/1998 5:26:00 AM
From: flickerful	Read Replies (1) \| Respond to of 9523

anthony...... good to see you at your usual dawn patrol post maneuvers. <g> i have read market theories and charts for what feels like an eternity; care to hazard a guess on "where we are going tomorrow...." randy

To: Anthony Wong who wrote (5113)	8/24/1998 6:20:00 AM
From: Anthony Wong	Respond to of 9523

08/24 03:23 *Phytopharm<PYM.L>Ssays Pfizer <PFE.N> interested in Other Products LONDON, Aug 24 (Reuters) - British botanical drugs group Phytopharm Plc <PYM.L> said on Monday that U.S. giant Pfizer Inc <PFE.N> was looking at other products in its portfolio in the wake of its decision to license obesity treatment P57. In a telephone interview with Reuters, Chief Executive Richard Dixey said the accord was also likely to act as a "shot in the arm" for ongoing negotiations with a number of other companies, including some of similar calibre to Pfizer. "I think this is a milestone. If you think of a partner, this is no diddlysquat (insignificant) pharmaceutical company, this is Pfizer -- it will make people sit up and think Phytopharm is talking to multinationals," Dixey said. "Pfizer is the right partner, it validates Phytopharm and as far as other negotiations (are concerned) it should provide a shot in the arm for those." moneynet.com@NEWS-P1&Index=1&HeadlineURL=../News/NewsHeadlines.asp&DISABLE_FORM=